Global Infectious Disease Testing Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Infectious Disease Testing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Infectious Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Molecular diagnostic test
  • 1.4.3 POCT
  • 1.4.4 Immunodiagnostic test
• 1.5 Market by Application
  • 1.5.1 Global Infectious Disease Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 HIV
  • 1.5.3 Respiratory
  • 1.5.4 HAIs
  • 1.5.5 Sexual health
  • 1.5.6 Tropical diseases
  • 1.5.7 Hepatitis
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Infectious Disease Testing Market Perspective (2015-2026)
• 2.2 Global Infectious Disease Testing Growth Trends by Regions
  • 2.2.1 Infectious Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Infectious Disease Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Infectious Disease Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Infectious Disease Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Infectious Disease Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Infectious Disease Testing Players by Market Size
  • 3.1.1 Global Top Infectious Disease Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Infectious Disease Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Infectious Disease Testing Market Concentration Ratio
  • 3.2.1 Global Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Testing Revenue in 2019
• 3.3 Infectious Disease Testing Key Players Head office and Area Served
• 3.4 Key Players Infectious Disease Testing Product Solution and Service
• 3.5 Date of Enter into Infectious Disease Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Infectious Disease Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Infectious Disease Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Infectious Disease Testing Market Size by Application (2015-2020)
• 5.2 Global Infectious Disease Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Infectious Disease Testing Market Size (2015-2020)
• 6.2 Infectious Disease Testing Key Players in North America (2019-2020)
• 6.3 North America Infectious Disease Testing Market Size by Type (2015-2020)
• 6.4 North America Infectious Disease Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Infectious Disease Testing Market Size (2015-2020)
• 7.2 Infectious Disease Testing Key Players in Europe (2019-2020)
• 7.3 Europe Infectious Disease Testing Market Size by Type (2015-2020)
• 7.4 Europe Infectious Disease Testing Market Size by Application (2015-2020)

8 China

• 8.1 China Infectious Disease Testing Market Size (2015-2020)
• 8.2 Infectious Disease Testing Key Players in China (2019-2020)
• 8.3 China Infectious Disease Testing Market Size by Type (2015-2020)
• 8.4 China Infectious Disease Testing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Infectious Disease Testing Market Size (2015-2020)
• 9.2 Infectious Disease Testing Key Players in Japan (2019-2020)
• 9.3 Japan Infectious Disease Testing Market Size by Type (2015-2020)
• 9.4 Japan Infectious Disease Testing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Infectious Disease Testing Market Size (2015-2020)
• 10.2 Infectious Disease Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Infectious Disease Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Infectious Disease Testing Market Size by Application (2015-2020)

11 India

• 11.1 India Infectious Disease Testing Market Size (2015-2020)
• 11.2 Infectious Disease Testing Key Players in India (2019-2020)
• 11.3 India Infectious Disease Testing Market Size by Type (2015-2020)
• 11.4 India Infectious Disease Testing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Infectious Disease Testing Market Size (2015-2020)
• 12.2 Infectious Disease Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Infectious Disease Testing Market Size by Type (2015-2020)
• 12.4 Central & South America Infectious Disease Testing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Diagnostics
  • 13.1.1 Abbott Diagnostics Company Details
  • 13.1.2 Abbott Diagnostics Business Overview
  • 13.1.3 Abbott Diagnostics Infectious Disease Testing Introduction
  • 13.1.4 Abbott Diagnostics Revenue in Infectious Disease Testing Business (2015-2020))
  • 13.1.5 Abbott Diagnostics Recent Development
• 13.2 Abbott
  • 13.2.1 Abbott Company Details
  • 13.2.2 Abbott Business Overview
  • 13.2.3 Abbott Infectious Disease Testing Introduction
  • 13.2.4 Abbott Revenue in Infectious Disease Testing Business (2015-2020)
  • 13.2.5 Abbott Recent Development
• 13.3 Beckman Coulter Diagnostics
  • 13.3.1 Beckman Coulter Diagnostics Company Details
  • 13.3.2 Beckman Coulter Diagnostics Business Overview
  • 13.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Introduction
  • 13.3.4 Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2015-2020)
  • 13.3.5 Beckman Coulter Diagnostics Recent Development
• 13.4 Roche
  • 13.4.1 Roche Company Details
  • 13.4.2 Roche Business Overview
  • 13.4.3 Roche Infectious Disease Testing Introduction
  • 13.4.4 Roche Revenue in Infectious Disease Testing Business (2015-2020)
  • 13.4.5 Roche Recent Development
• 13.5 Siemens Healthcare
  • 13.5.1 Siemens Healthcare Company Details
  • 13.5.2 Siemens Healthcare Business Overview
  • 13.5.3 Siemens Healthcare Infectious Disease Testing Introduction
  • 13.5.4 Siemens Healthcare Revenue in Infectious Disease Testing Business (2015-2020)
  • 13.5.5 Siemens Healthcare Recent Development
• 13.6 Abaxis
  • 13.6.1 Abaxis Company Details
  • 13.6.2 Abaxis Business Overview
  • 13.6.3 Abaxis Infectious Disease Testing Introduction
  • 13.6.4 Abaxis Revenue in Infectious Disease Testing Business (2015-2020)
  • 13.6.5 Abaxis Recent Development
• 13.7 Acon Laboratories
  • 13.7.1 Acon Laboratories Company Details
  • 13.7.2 Acon Laboratories Business Overview
  • 13.7.3 Acon Laboratories Infectious Disease Testing Introduction
  • 13.7.4 Acon Laboratories Revenue in Infectious Disease Testing Business (2015-2020)
  • 13.7.5 Acon Laboratories Recent Development
• 13.8 Avioq
  • 13.8.1 Avioq Company Details
  • 13.8.2 Avioq Business Overview
  • 13.8.3 Avioq Infectious Disease Testing Introduction
  • 13.8.4 Avioq Revenue in Infectious Disease Testing Business (2015-2020)
  • 13.8.5 Avioq Recent Development
• 13.9 BD
  • 13.9.1 BD Company Details
  • 13.9.2 BD Business Overview
  • 13.9.3 BD Infectious Disease Testing Introduction
  • 13.9.4 BD Revenue in Infectious Disease Testing Business (2015-2020)
  • 13.9.5 BD Recent Development
• 13.10 Bio-Rad Laboratories
  • 13.10.1 Bio-Rad Laboratories Company Details
  • 13.10.2 Bio-Rad Laboratories Business Overview
  • 13.10.3 Bio-Rad Laboratories Infectious Disease Testing Introduction
  • 13.10.4 Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2015-2020)
  • 13.10.5 Bio-Rad Laboratories Recent Development
• 13.11 Cavidi
  • 10.11.1 Cavidi Company Details
  • 10.11.2 Cavidi Business Overview
  • 10.11.3 Cavidi Infectious Disease Testing Introduction
  • 10.11.4 Cavidi Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.11.5 Cavidi Recent Development
• 13.12 Cepheid
  • 10.12.1 Cepheid Company Details
  • 10.12.2 Cepheid Business Overview
  • 10.12.3 Cepheid Infectious Disease Testing Introduction
  • 10.12.4 Cepheid Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.12.5 Cepheid Recent Development
• 13.13 Chembio Diagnostic Systems
  • 10.13.1 Chembio Diagnostic Systems Company Details
  • 10.13.2 Chembio Diagnostic Systems Business Overview
  • 10.13.3 Chembio Diagnostic Systems Infectious Disease Testing Introduction
  • 10.13.4 Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.13.5 Chembio Diagnostic Systems Recent Development
• 13.14 Clarity Diagnostics
  • 10.14.1 Clarity Diagnostics Company Details
  • 10.14.2 Clarity Diagnostics Business Overview
  • 10.14.3 Clarity Diagnostics Infectious Disease Testing Introduction
  • 10.14.4 Clarity Diagnostics Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.14.5 Clarity Diagnostics Recent Development
• 13.15 EMD Millipore
  • 10.15.1 EMD Millipore Company Details
  • 10.15.2 EMD Millipore Business Overview
  • 10.15.3 EMD Millipore Infectious Disease Testing Introduction
  • 10.15.4 EMD Millipore Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.15.5 EMD Millipore Recent Development
• 13.16 Epitope Diagnostic
  • 10.16.1 Epitope Diagnostic Company Details
  • 10.16.2 Epitope Diagnostic Business Overview
  • 10.16.3 Epitope Diagnostic Infectious Disease Testing Introduction
  • 10.16.4 Epitope Diagnostic Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.16.5 Epitope Diagnostic Recent Development
• 13.17 Gold Standard Diagnostics
  • 10.17.1 Gold Standard Diagnostics Company Details
  • 10.17.2 Gold Standard Diagnostics Business Overview
  • 10.17.3 Gold Standard Diagnostics Infectious Disease Testing Introduction
  • 10.17.4 Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.17.5 Gold Standard Diagnostics Recent Development
• 13.18 Hologic
  • 10.18.1 Hologic Company Details
  • 10.18.2 Hologic Business Overview
  • 10.18.3 Hologic Infectious Disease Testing Introduction
  • 10.18.4 Hologic Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.18.5 Hologic Recent Development
• 13.19 Immunetics
  • 10.19.1 Immunetics Company Details
  • 10.19.2 Immunetics Business Overview
  • 10.19.3 Immunetics Infectious Disease Testing Introduction
  • 10.19.4 Immunetics Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.19.5 Immunetics Recent Development
• 13.20 InBios International
  • 10.20.1 InBios International Company Details
  • 10.20.2 InBios International Business Overview
  • 10.20.3 InBios International Infectious Disease Testing Introduction
  • 10.20.4 InBios International Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.20.5 InBios International Recent Development
• 13.21 Life Technologies
  • 10.21.1 Life Technologies Company Details
  • 10.21.2 Life Technologies Business Overview
  • 10.21.3 Life Technologies Infectious Disease Testing Introduction
  • 10.21.4 Life Technologies Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.21.5 Life Technologies Recent Development
• 13.22 Maxim Biomedical
  • 10.22.1 Maxim Biomedical Company Details
  • 10.22.2 Maxim Biomedical Business Overview
  • 10.22.3 Maxim Biomedical Infectious Disease Testing Introduction
  • 10.22.4 Maxim Biomedical Revenue in Infectious Disease Testing Business (2015-2020)
  • 10.22.5 Maxim Biomedical Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer